Avanos Medical files Q3 2025 earnings release; detailed results not provided in filing text

AVANOS MEDICAL, INC.

2025-Q3 EPS reported -$1.55 revenue$520,300,000

Press release for three and nine months ended September 30, 2025 furnished as Exhibit 99.1.
No specific financial figures (revenue, EPS, segments) available in the filing materials submitted.
Earnings release date: November 5, 2025; coverage period Q3 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.